+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hemophilia Treatment Market by Therapeutic Class (Gene Therapy, Replacement Therapy), Treatment Mode (On-Demand, Prophylaxis), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Hemophilia Treatment Market by Therapeutic Class (Gene Therapy, Replacement Therapy), Treatment Mode (On-Demand, Prophylaxis), End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Hemophilia Treatment Market by Therapeutic Class (Gene Therapy, Replacement Therapy), Treatment Mode (On-Demand, Prophylaxis), End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4829909
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The hemophilia treatment market is experiencing significant transformation as innovation and patient-centric care models reshape therapeutic and operational strategies. Senior executives and decision-makers must adapt to these changes, leveraging emerging technologies and stakeholder partnerships to maintain a resilient and value-driven approach in an evolving global landscape.

Market Snapshot: Hemophilia Treatment Market

The Hemophilia Treatment Market grew from USD 15.23 billion in 2024 to USD 16.26 billion in 2025. It is expected to continue growing at a CAGR of 6.47%, reaching USD 22.19 billion by 2030. This sustained growth reflects ongoing scientific breakthroughs, expanded access, and strategic collaborations among key stakeholders. The market is characterized by a strong pipeline of gene-based innovations, enhanced integration of digital health tools, and a dynamic regulatory environment shaping value-based care initiatives.

Scope & Segmentation

  • Therapeutic Class: Gene therapy and replacement therapy solutions represent the leading approaches, each serving distinct clinical needs within the patient population.
  • Treatment Mode: On-demand therapies enable immediate management of bleeding events, while prophylaxis regimens are designed to provide long-term bleeding prevention and improve patients' daily quality of life.
  • End User: Home healthcare settings are increasingly supporting patient autonomy through self-administration, alongside hospitals and specialized clinics that provide advanced infusion care and clinical oversight.
  • Distribution Channel: Hemophilia treatments are delivered through both hospital pharmacy networks and retail pharmacy outlets, each demanding specific compliance and reimbursement protocols.
  • Regional Coverage:
    • Americas: United States, Canada, Mexico, Brazil, Argentina, and key US states including California, Texas, New York, Florida, Illinois, Pennsylvania, and Ohio
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Company Coverage: Roche Holding AG, Takeda Pharmaceutical Company Limited, Swedish Orphan Biovitrium AB, Bayer AG, CSL Limited, Novo Nordisk A/S, Pfizer Inc., Octapharma AG, Grifols, S.A., BioMarin Pharmaceutical Inc.

Key Takeaways

  • Rapid scientific and digital advances are enabling more precise and individualized hemophilia care, pushing the adoption of patient-reported outcomes and real-time monitoring.
  • Collaborative models are evolving, uniting biopharmaceutical leaders, healthcare providers, and payers to address both acute and long-term treatment demands.
  • Gene-based solutions are redefining therapeutic expectations, prompting shifts from conventional factor replacement toward potentially curative approaches.
  • Integration of predictive analytics and digital platforms is equipping stakeholders with actionable insights to optimize therapy adherence and care delivery.
  • Manufacturers and care centers are strengthening supply chain frameworks and operational agility to overcome global access barriers and maintain continuity of care.
  • Dynamic reimbursement models and risk-sharing agreements are aligning payment mechanisms more closely with measurable patient outcomes and long-term sustainability.

Tariff Impact: Navigating 2025 U.S. Policy Changes

For 2025, new United States tariff regulations have introduced important operational challenges along the hemophilia treatment supply chain. Increased import duties on essential raw materials have led manufacturers to reevaluate sourcing and buffering strategies, diversifying suppliers and safeguarding production processes. As downstream pricing pressures intensify, hospitals and retail pharmacies are adapting contract structures, improving negotiation agility, and leveraging integrated logistics to uphold uninterrupted patient access amid evolving fiscal policies.

Methodology & Data Sources

This report combines secondary research, primary stakeholder interviews, and structured quantitative data collection to produce a reliable and actionable analysis. The methodology includes an extensive review of clinical literature, input from industry and patient leaders, and scenario analysis for resilience testing. Data integrity is maintained through cross-validation protocols and comprehensive peer review.

Why This Report Matters

  • Supports strategic planning by illuminating both disruptive innovations and operational best practices shaping the hemophilia treatment landscape.
  • Equips senior leaders with a multi-dimensional view of market dynamics, segment performance, and partnership trends necessary for resilient decision making.
  • Delivers actionable intelligence for aligning product development, supply chain, and contracting strategies with global trends and local challenges.

Conclusion

Hemophilia treatment is entering a new era driven by gene-based therapies, digital innovation, and collaborative care models. Stakeholders who align their strategies with these evolving imperatives will be positioned to deliver superior clinical and operational outcomes for patients, providers, and partners.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of CRISPR-based gene therapy approaches in hemophilia A to achieve durable factor expression and reduce lifelong infusion requirements
5.2. Expansion of bispecific monoclonal antibody treatments such as emicizumab reshaping prophylaxis protocols for hemophilia A patients with inhibitor development risk
5.3. Growing integration of digital treatment adherence platforms and wearable technology to monitor bleeding episodes and infusion compliance in real time
5.4. Regulatory and pricing challenges associated with one-time gene therapies like valoctocogene roxaparvovec influencing market access and reimbursement decisions
5.5. Utilization of real-world data from international hemophilia registries to inform personalized prophylactic regimens and comprehensive health economic modeling
5.6. Development of extended half-life recombinant factor VIII and IX products extending dosing intervals to improve patient convenience and quality of life
5.7. Emergence of patient-centric outcome measures and telemedicine services optimizing remote care management and adherence support for hemophilia populations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Hemophilia Treatment Market, by Therapeutic Class
8.1. Introduction
8.2. Gene Therapy
8.3. Replacement Therapy
9. Hemophilia Treatment Market, by Treatment Mode
9.1. Introduction
9.2. On-Demand
9.3. Prophylaxis
10. Hemophilia Treatment Market, by End User
10.1. Introduction
10.2. Home Healthcare
10.3. Hospitals
10.4. Specialized Clinics
11. Hemophilia Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Retail Pharmacy
12. Americas Hemophilia Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Hemophilia Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Hemophilia Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Roche Holding AG
15.3.2. Takeda Pharmaceutical Company Limited
15.3.3. Swedish Orphan Biovitrium AB
15.3.4. Bayer AG
15.3.5. CSL Limited
15.3.6. Novo Nordisk A/S
15.3.7. Pfizer Inc.
15.3.8. Octapharma AG
15.3.9. Grifols, S.A.
15.3.10. BioMarin Pharmaceutical Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. HEMOPHILIA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. HEMOPHILIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. HEMOPHILIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. HEMOPHILIA TREATMENT MARKET: RESEARCHAI
FIGURE 24. HEMOPHILIA TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. HEMOPHILIA TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. HEMOPHILIA TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HEMOPHILIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY REPLACEMENT THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY REPLACEMENT THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY ON-DEMAND, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY ON-DEMAND, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY PROPHYLAXIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY SPECIALIZED CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HEMOPHILIA TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 36. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 37. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 38. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 39. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 40. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 41. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 44. AMERICAS HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 45. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 46. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 47. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 48. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 49. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 50. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 51. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 52. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 53. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 54. UNITED STATES HEMOPHILIA TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 55. CANADA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 56. CANADA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 57. CANADA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 58. CANADA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 59. CANADA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. CANADA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. CANADA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. CANADA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. MEXICO HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 64. MEXICO HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 65. MEXICO HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 66. MEXICO HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 67. MEXICO HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. MEXICO HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. MEXICO HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. MEXICO HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. BRAZIL HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 72. BRAZIL HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 73. BRAZIL HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 74. BRAZIL HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 75. BRAZIL HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. BRAZIL HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. BRAZIL HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. BRAZIL HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. ARGENTINA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 80. ARGENTINA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 81. ARGENTINA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 82. ARGENTINA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 83. ARGENTINA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. ARGENTINA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. ARGENTINA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. ARGENTINA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 98. UNITED KINGDOM HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 100. UNITED KINGDOM HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. UNITED KINGDOM HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 104. UNITED KINGDOM HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 105. GERMANY HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 106. GERMANY HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 107. GERMANY HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 108. GERMANY HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 109. GERMANY HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. GERMANY HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. GERMANY HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. GERMANY HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. FRANCE HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 114. FRANCE HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 115. FRANCE HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 116. FRANCE HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 117. FRANCE HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. FRANCE HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. FRANCE HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. FRANCE HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. RUSSIA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 122. RUSSIA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 123. RUSSIA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 124. RUSSIA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 125. RUSSIA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. RUSSIA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. RUSSIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. RUSSIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. ITALY HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 130. ITALY HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 131. ITALY HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 132. ITALY HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 133. ITALY HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. ITALY HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. ITALY HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 136. ITALY HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 137. SPAIN HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 138. SPAIN HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 139. SPAIN HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 140. SPAIN HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 141. SPAIN HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. SPAIN HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. SPAIN HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. SPAIN HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 154. SAUDI ARABIA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 156. SAUDI ARABIA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. SAUDI ARABIA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. SAUDI ARABIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 162. SOUTH AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 164. SOUTH AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. SOUTH AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. SOUTH AFRICA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. DENMARK HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 170. DENMARK HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 171. DENMARK HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 172. DENMARK HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 173. DENMARK HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. DENMARK HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. DENMARK HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. DENMARK HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. NETHERLANDS HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 178. NETHERLANDS HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 179. NETHERLANDS HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 180. NETHERLANDS HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 181. NETHERLANDS HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. NETHERLANDS HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. NETHERLANDS HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. NETHERLANDS HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. QATAR HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 186. QATAR HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 187. QATAR HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 188. QATAR HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 189. QATAR HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. QATAR HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. QATAR HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. QATAR HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. FINLAND HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 194. FINLAND HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 195. FINLAND HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 196. FINLAND HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 197. FINLAND HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. FINLAND HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. FINLAND HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. FINLAND HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. SWEDEN HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 202. SWEDEN HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 203. SWEDEN HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 204. SWEDEN HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 205. SWEDEN HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. SWEDEN HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. SWEDEN HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. SWEDEN HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. NIGERIA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 210. NIGERIA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 211. NIGERIA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 212. NIGERIA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 213. NIGERIA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. NIGERIA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. NIGERIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. NIGERIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. EGYPT HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 218. EGYPT HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 219. EGYPT HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 220. EGYPT HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 221. EGYPT HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. EGYPT HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. EGYPT HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. EGYPT HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. TURKEY HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 226. TURKEY HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 227. TURKEY HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 228. TURKEY HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 229. TURKEY HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. TURKEY HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. TURKEY HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. TURKEY HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. ISRAEL HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 234. ISRAEL HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 235. ISRAEL HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 236. ISRAEL HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 237. ISRAEL HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. ISRAEL HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. ISRAEL HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. ISRAEL HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. NORWAY HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 242. NORWAY HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 243. NORWAY HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 244. NORWAY HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 245. NORWAY HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. NORWAY HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. NORWAY HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. NORWAY HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. POLAND HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 250. POLAND HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 251. POLAND HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 252. POLAND HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 253. POLAND HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. POLAND HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. POLAND HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. POLAND HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. SWITZERLAND HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 258. SWITZERLAND HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 259. SWITZERLAND HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 260. SWITZERLAND HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 261. SWITZERLAND HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. SWITZERLAND HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. SWITZERLAND HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. SWITZERLAND HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 266. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 268. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 274. ASIA-PACIFIC HEMOPHILIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 275. CHINA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 276. CHINA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 277. CHINA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 278. CHINA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 279. CHINA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. CHINA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. CHINA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. CHINA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. INDIA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 284. INDIA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 285. INDIA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 286. INDIA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 287. INDIA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. INDIA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. INDIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. INDIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. JAPAN HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 292. JAPAN HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 293. JAPAN HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 294. JAPAN HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 295. JAPAN HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. JAPAN HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. JAPAN HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. JAPAN HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. AUSTRALIA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 300. AUSTRALIA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 301. AUSTRALIA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 302. AUSTRALIA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 303. AUSTRALIA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. AUSTRALIA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. AUSTRALIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. AUSTRALIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. SOUTH KOREA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 308. SOUTH KOREA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 309. SOUTH KOREA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 310. SOUTH KOREA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 311. SOUTH KOREA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. SOUTH KOREA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. SOUTH KOREA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. SOUTH KOREA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. INDONESIA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 316. INDONESIA HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 317. INDONESIA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 318. INDONESIA HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 319. INDONESIA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 320. INDONESIA HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 321. INDONESIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. INDONESIA HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. THAILAND HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 324. THAILAND HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 325. THAILAND HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 326. THAILAND HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 327. THAILAND HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. THAILAND HEMOPHILIA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. THAILAND HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 330. THAILAND HEMOPHILIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 331. PHILIPPINES HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2024 (USD MILLION)
TABLE 332. PHILIPPINES HEMOPHILIA TREATMENT MARKET SIZE, BY THERAPEUTIC CLASS, 2025-2030 (USD MILLION)
TABLE 333. PHILIPPINES HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2018-2024 (USD MILLION)
TABLE 334. PHILIPPINES HEMOPHILIA TREATMENT MARKET SIZE, BY TREATMENT MODE, 2025-2030 (USD MILLION)
TABLE 335. PHILIPPINES HEMOPHILIA TREATMENT MARKET SIZE, BY END USER,

Samples

Loading
LOADING...

Companies Mentioned

  • Roche Holding AG
  • Takeda Pharmaceutical Company Limited
  • Swedish Orphan Biovitrium AB
  • Bayer AG
  • CSL Limited
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Octapharma AG
  • Grifols, S.A.
  • BioMarin Pharmaceutical Inc.

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 16.26 Billion
Forecasted Market Value ( USD ) by 2030 $ 22.19 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Hemophilia Market Size, Share & Trends Analysis Report By Type (Hemophilia A, Hemophilia B), By Treatment Type (On-demand, Cure), By Therapy, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Hemophilia Market Size, Share & Trends Analysis Report By Type (Hemophilia A, Hemophilia B), By Treatment Type (On-demand, Cure), By Therapy, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 110 Pages
  • Global
From
Hemophilia Treatment - Global Strategic Business Report - Product Image

Hemophilia Treatment - Global Strategic Business Report

  • Report
  • 476 Pages
  • Global
From
Hemophilia Drugs - Global Strategic Business Report - Product Image

Hemophilia Drugs - Global Strategic Business Report

  • Report
  • 182 Pages
  • Global
From
Hemophilia A Treatment Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Hemophilia A Treatment Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 186 Pages
  • Global
From
Acquired Hemophilia Treatment Market Report 2025 - Product Image

Acquired Hemophilia Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Hemophilia Drug Market

The Hemophilia Drug market is a subset of the larger Hematological Drugs market. Hemophilia drugs are used to treat and prevent bleeding episodes in people with hemophilia, a rare genetic disorder. These drugs are typically administered intravenously or subcutaneously and are designed to replace the missing clotting factor in the patient's blood. Commonly used hemophilia drugs include recombinant factor VIII and IX, as well as plasma-derived factor VIII and IX. The Hemophilia Drug market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Pfizer, Novo Nordisk, Bayer, Biogen, CSL Behring, and Shire. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.